The Association for Molecular Pathology announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing ...

Blood levels of a protein called neurofilament light chain rise significantly in MS patients up to a year before they have a ...

June is Alzheimer’s and Brain Health Awareness Month. More than 7 million people have Alzheimer’s disease here in the United ...

NEW YORK – The Association for Molecular Pathology on Tuesday published best practice recommendations for the design and validation of clinical tests for homologous recombination deficiency. The ...

The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations for clinical laboratories ...

The companies are codeveloping a test that leverages Veravas’ proprietary VeraBIND ™ technology with Phanes’ biological intellectual property on tau pathology to detect active disease by ...

A clinical diagnostics company and biotech firm have announced a partnership to develop a blood-based tau pathology test that would assist in the diagnosis of Alzheimer’s disease. In a press ...

The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Digital ...

Leaders most often associate it with measurable benefits: more effective therapies (80%), more accurate diagnoses (75%), and improved patient outcomes (61%). Some also point to increased collaboration ...

Digital pathology software company Fujifilm Healthcare Europe and Ibex Medical Analytics, a company specializing in AI-powered cancer diagnostics in pathology, announce a formal partnership to support ...